5Liu BC, He L, He G, et al. A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: towards a made-in-China orphan drug policy. J Public Health Policy, 2010, 31 (4) :407-420.
6Wang JB, Guo J J, Yang L, et al. Rare diseases and legislation in China. Lancet, 2010, 375(9716):708-709.
